Cargando…

Measurement of Circulating Cell‐Free DNA in Relation to 18F‐Fluorocholine PET/CT Imaging in Chemotherapy‐Treated Advanced Prostate Cancer

Purpose: To examine the effects of chemotherapy on circulating cell‐free DNA (cfDNA) composition in relation to investigational whole‐body measurement of tumor activity by fluorine‐18 fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) in hormone‐refractory prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwee, Sandi, Song, Min‐Ae, Cheng, Iona, Loo, Lenora, Tiirikainen, Maarit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Inc 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500883/ https://www.ncbi.nlm.nih.gov/pubmed/22376260 http://dx.doi.org/10.1111/j.1752-8062.2011.00375.x

Ejemplares similares

Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging
por: Kwee, Sandi A., et al.
Publicado: (2012)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT
por: Kwee, Sandi A., et al.
Publicado: (2015)

Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer
por: Kim, Jung Kwon, et al.
Publicado: (2022)

Detection of an undescended parathyroid adenoma with (18)F-fluorocholine PET/CT
por: Booij, J., et al.
Publicado: (2022)

Preoperative Imaging with [(18)F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
por: Dekorsy, Franziska J., et al.
Publicado: (2022)

Incidental Findings on (18) F-Fluorocholine PET/CT for Parathyroid Imaging
por: Broos, Wouter A.M., et al.
Publicado: (2022)

Intra-vagal parathyroid adenoma on digital PET/CT with (18)F-fluorocholine
por: Mainta, Ismini C., et al.
Publicado: (2021)

[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019)

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer
por: Sepulcri, Matteo, et al.
Publicado: (2021)

Detection of recurrence sites using (18)F-fluorocholine PET/CT in prostate cancer patients with PSA failure
por: Kim, Dong-Yun, et al.
Publicado: (2023)

Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT
por: Rep, Sebastijan, et al.
Publicado: (2015)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

COVID-19 Pneumonia was Incidentally Detected on (18)F-Fluorocholine PET/CT in a Work-up for Prostate Cancer
por: Sahel, Omar Ait, et al.
Publicado: (2022)

Differentiation of hepatocellular adenoma and focal nodular hyperplasia using (18)F-fluorocholine PET/CT
por: van den Esschert, Jacomina W., et al.
Publicado: (2010)

(18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism
por: Latge, Adrien, et al.
Publicado: (2021)

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
por: De Giorgi, Ugo, et al.
Publicado: (2014)

Diagnostic Performance of [(18)F]Fluorocholine and [(68)Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
por: Paymani, Zeinab, et al.
Publicado: (2020)

(18)F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism
por: Pretet, Valentin, et al.
Publicado: (2020)

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer
por: Conteduca, V., et al.
Publicado: (2017)

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by (18)F-Fluorocholine combined with (18)F-NaF PET/CT
por: Xiong, Lin, et al.
Publicado: (2021)

Interim and end-treatment (18)F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride
por: García Vicente, Ana María, et al.
Publicado: (2021)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

Comparison of (18)F-sodium fluoride PET/CT, (18)F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
por: Gauthé, Mathieu, et al.
Publicado: (2020)

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

Hyperfunctioning parathyroid gland and skeletal involvement on [(18)F]fluorocholine PET/CT: one look with two views
por: Nappi, Carmela, et al.
Publicado: (2022)

Dural Metastases of Advanced Prostate Cancer Detected by (18)F-Fluorocholine
por: Morassi, Mauro, et al.
Publicado: (2020)

Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers
por: Kwee, Sandi A., et al.
Publicado: (2021)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [(18)F]DCFPyL-PET: comparison to [(18)F]fluorocholine-PET
por: Yang, Dae-Myoung, et al.
Publicado: (2021)

Incremental role of (18)F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism
por: Behera, Abhishek, et al.
Publicado: (2016)

The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging
por: Fischli, Stefan, et al.
Publicado: (2018)

Misleading localization by (18)F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report
por: Mukhtar, Noha N, et al.
Publicado: (2021)

Does (18)F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
por: Imperiale, Alessio, et al.
Publicado: (2023)

Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [(18)F]‐fluorocholine PET‐CT using histopathology as a reference
por: Bjöersdorff, Mimmi, et al.
Publicado: (2022)

Prognostic Value of (18)F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
por: Quaquarini, E., et al.
Publicado: (2019)

Phase III Study of (18)F-PSMA-1007 Versus (18)F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
por: Olivier, Pierre, et al.
Publicado: (2023)

(18)F-Fluorocholine PET–CT enables minimal invasive parathyroidectomy in patients with negative sestamibi SPECT–CT and ultrasound: A case report
por: Kluijfhout, Wouter P., et al.
Publicado: (2015)

Troubleshooting for F-18 Fluorocholine Synthesis: An Institutional Experience
por: Vatsa, Rakhee, et al.
Publicado: (2018)

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer
por: Hodolic, Marina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1563qd7lk3omsjhh88csb26g9r